Lovo-cel in SCD Pooled Analysis
Pooled Analysis of Phase I/II and Phase III Trials of Lovotibeglogene Autotemcel Gene Therapy in Patients With Sickle Cell Disease

Released: December 13, 2023

Activity

Progress
1
Course Completed